Use of low-dose peginterferon alpha-2a (40kD) 628 (pegasys (R)) to treat hepatitis C-infected end-stage renal disease patients undergoing haemodialysis: Interim results from a randomised study

Author
Messinger, D.
Besisik, F.
Samuel, D.
Junker, H.
Cheinquer, H.
Peck-Radosavljevic, M.
Boletis, J.
Ferraz, M. Lucia
Alric, L.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/33216
https://doi.org/10.1016/s0168-8278(07)62226-0
Collections